LEI: 213800NNT42FFIZB1T09 
18 September 2026

Transactions in Own Shares

Foresight Group Holdings Limited (“Foresight”, the “Group”), a leading investment manager in real assets and providing capital for growth, announces that, in accordance with the terms of its current share buyback programme announced on 10 April 2025 (the “Share Buyback”), the Group purchased the following number of its ordinary shares of £nil par value (“Ordinary Shares”) each through JOH Berenberg, Gossler & Co KG (which is trading for these purposes as Berenberg) (“Berenberg”).

Date of purchase: 11 September 2026
Aggregate number of Ordinary Shares purchased: 10,000
Lowest price paid per share (GBp): 468.50
Highest price paid per share (GBp): 473.00
Volume weighted average price paid per share (GBp): 471.982400

Date of purchase: 14 September 2026
Aggregate number of Ordinary Shares purchased: 10,000
Lowest price paid per share (GBp): 468.00
Highest price paid per share (GBp): 472.50
Volume weighted average price paid per share (GBp): 469.870650

Date of purchase: 15 September 2026
Aggregate number of Ordinary Shares purchased: 10,000
Lowest price paid per share (GBp): 455.00
Highest price paid per share (GBp): 463.50
Volume weighted average price paid per share (GBp): 458.902250

Date of purchase: 16 September 2026
Aggregate number of Ordinary Shares purchased: 10,000
Lowest price paid per share (GBp): 458.50
Highest price paid per share (GBp): 465.50
Volume weighted average price paid per share (GBp): 462.954000

Date of purchase: 17 September 2026
Aggregate number of Ordinary Shares purchased: 10,000
Lowest price paid per share (GBp): 439.00
Highest price paid per share (GBp): 445.00
Volume weighted average price paid per share (GBp): 442.814900

Once settled, the purchased shares will be held by the Group in treasury, which means they will have no voting rights while they are held in treasury. Under the current Buyback Programme, an aggregate of 7,481,201 Ordinary Shares have been bought back.

Additionally, 30,190 shares have been transferred out of treasury to facilitate the exercise of options issued in accordance with the terms of the Performance Shares Plan. 

As a result of the above, of the Group’s 116,347,803 Ordinary Shares currently in issue, a total of 111,329,491 have voting rights and 5,018,312 held in treasury and are therefore non-voting. The total number of voting shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in the Group under the FCA’s Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback.

Individual information:

Number of ordinary shares purchased Transaction price (GBp share) Time of transaction (UK Time) Trading Venue    
   
370 468.500 11/09/2026 08:03:38 LSE    
98 468.500 11/09/2026 08:49:01 LSE    
163 468.500 11/09/2026 08:49:01 LSE    
185 469.000 11/09/2026 09:26:56 LSE    
344 471.500 11/09/2026 10:59:18 LSE    
185 473.000 11/09/2026 11:25:05 LSE    
472 473.000 11/09/2026 11:54:59 LSE    
30 471.500 11/09/2026 12:26:01 LSE    
444 471.500 11/09/2026 12:28:59 LSE    
189 471.500 11/09/2026 12:28:59 LSE    
420 470.500 11/09/2026 13:30:02 LSE    
121 473.000 11/09/2026 14:01:10 LSE    
64 473.000 11/09/2026 14:01:11 LSE    
185 473.000 11/09/2026 14:03:01 LSE    
187 473.000 11/09/2026 14:03:01 LSE    
81 472.500 11/09/2026 14:10:23 LSE    
83 472.500 11/09/2026 14:10:23 LSE    
284 472.500 11/09/2026 14:10:23 LSE    
184 472.500 11/09/2026 14:10:23 LSE    
400 472.500 11/09/2026 14:10:23 LSE    
400 472.500 11/09/2026 14:11:04 LSE    
413 472.500 11/09/2026 14:11:04 LSE    
400 472.500 11/09/2026 14:11:04 LSE    
400 472.500 11/09/2026 14:11:04 LSE    
400 472.500 11/09/2026 14:11:04 LSE    
75 472.500 11/09/2026 14:11:43 LSE    
325 472.500 11/09/2026 14:23:27 LSE    
66 472.500 11/09/2026 14:23:27 LSE    
334 472.500 11/09/2026 14:23:27 LSE    
400 472.500 11/09/2026 14:23:28 LSE    
400 472.500 11/09/2026 14:23:28 LSE    
368 472.500 11/09/2026 14:23:28 LSE    
400 472.500 11/09/2026 14:23:28 LSE    
377 472.000 11/09/2026 14:23:28 LSE    
193 471.500 11/09/2026 14:33:15 LSE    
172 471.500 11/09/2026 14:41:00 LSE    
34 471.500 11/09/2026 14:41:00 LSE    
56 472.000 11/09/2026 14:52:20 LSE    
96 472.000 11/09/2026 14:52:20 LSE    
202 472.000 11/09/2026 14:52:20 LSE    
1157 470.500 14/09/2026 08:13:12 LSE    
292 470.500 14/09/2026 08:13:12 LSE    
184 470.000 14/09/2026 08:24:22 LSE    
1364 469.000 14/09/2026 08:26:20 LSE    
276 469.000 14/09/2026 08:26:20 LSE    
306 468.000 14/09/2026 08:37:09 LSE    
1468 469.000 14/09/2026 08:40:13 LSE    
184 470.000 14/09/2026 08:41:08 LSE    
916 469.000 14/09/2026 08:41:24 LSE    
184 469.500 14/09/2026 08:41:45 LSE    
440 470.000 14/09/2026 08:43:46 LSE    
512 470.000 14/09/2026 08:45:43 LSE    
1633 470.000 14/09/2026 08:45:43 LSE    
1084 472.500 14/09/2026 08:47:12 LSE    
315 463.500 15/09/2026 08:02:12 LSE    
513 463.500 15/09/2026 08:02:12 LSE    
186 461.000 15/09/2026 08:09:28 LSE    
384 461.000 15/09/2026 08:09:28 LSE    
87 457.500 15/09/2026 08:41:24 LSE    
855 457.500 15/09/2026 08:41:24 LSE    
192 458.000 15/09/2026 08:44:56 LSE    
450 458.000 15/09/2026 08:44:56 LSE    
225 457.000 15/09/2026 08:55:34 LSE    
505 458.000 15/09/2026 09:24:17 LSE    
59 458.000 15/09/2026 09:34:07 LSE    
186 456.500 15/09/2026 09:48:09 LSE    
201 456.000 15/09/2026 10:13:45 LSE    
229 455.000 15/09/2026 10:19:33 LSE    
486 456.500 15/09/2026 10:43:05 LSE    
215 456.500 15/09/2026 10:43:59 LSE    
186 459.500 15/09/2026 11:31:04 LSE    
1403 460.000 15/09/2026 12:06:22 LSE    
634 460.000 15/09/2026 12:40:27 LSE    
146 460.000 15/09/2026 12:40:27 LSE    
186 459.000 15/09/2026 13:26:34 LSE    
202 459.500 15/09/2026 13:48:07 LSE    
186 460.000 15/09/2026 14:06:10 LSE    
502 459.500 15/09/2026 14:06:36 LSE    
770 457.500 15/09/2026 14:48:28 LSE    
186 458.000 15/09/2026 15:14:09 LSE    
511 458.000 15/09/2026 15:51:04 LSE    
1 461.000 16/09/2026 08:40:17 LSE    
5 461.000 16/09/2026 08:40:17 LSE    
147 461.000 16/09/2026 08:40:17 LSE    
188 461.000 16/09/2026 08:40:37 LSE    
512 459.500 16/09/2026 08:54:04 LSE    
116 459.500 16/09/2026 08:54:04 LSE    
188 458.500 16/09/2026 09:26:33 LSE    
188 462.000 16/09/2026 09:46:46 LSE    
188 462.000 16/09/2026 09:48:06 LSE    
188 463.000 16/09/2026 09:49:08 LSE    
188 463.000 16/09/2026 09:49:14 LSE    
340 463.000 16/09/2026 09:51:12 LSE    
188 462.500 16/09/2026 09:51:46 LSE    
188 463.000 16/09/2026 09:54:01 LSE    
188 462.500 16/09/2026 09:58:29 LSE    
416 462.500 16/09/2026 09:58:29 LSE    
536 461.500 16/09/2026 10:18:39 LSE    
188 461.500 16/09/2026 11:05:50 LSE    
188 462.500 16/09/2026 11:40:47 LSE    
188 462.000 16/09/2026 11:40:58 LSE    
218 462.000 16/09/2026 11:40:58 LSE    
188 463.500 16/09/2026 12:26:10 LSE    
1649 463.000 16/09/2026 12:26:26 LSE    
158 462.500 16/09/2026 12:36:58 LSE    
376 462.500 16/09/2026 12:36:58 LSE    
188 465.500 16/09/2026 13:51:09 LSE    
1577 465.500 16/09/2026 13:53:25 LSE    
269 465.500 16/09/2026 13:53:25 LSE    
188 464.000 16/09/2026 14:03:26 LSE    
188 464.000 16/09/2026 14:03:36 LSE    
672 463.500 16/09/2026 14:05:45 LSE    
509 445.000 17/09/2026 08:00:37 LSE    
1154 445.000 17/09/2026 08:03:43 LSE    
497 445.000 17/09/2026 08:04:16 LSE    
898 443.500 17/09/2026 08:16:00 LSE    
210 441.500 17/09/2026 08:22:25 LSE    
523 442.000 17/09/2026 08:26:11 LSE    
186 441.000 17/09/2026 08:28:02 LSE    
194 441.500 17/09/2026 08:32:37 LSE    
224 444.000 17/09/2026 08:36:00 LSE    
1705 443.500 17/09/2026 08:38:16 LSE    
186 443.500 17/09/2026 08:40:13 LSE    
220 443.500 17/09/2026 08:45:05 LSE    
220 443.500 17/09/2026 08:45:20 LSE    
228 444.000 17/09/2026 09:16:04 LSE    
191 444.000 17/09/2026 09:16:04 LSE    
472 442.000 17/09/2026 09:19:20 LSE    
186 443.000 17/09/2026 09:28:35 LSE    
429 441.500 17/09/2026 10:03:33 LSE    
187 441.000 17/09/2026 10:14:30 LSE    
239 441.000 17/09/2026 10:14:32 LSE    
406 439.000 17/09/2026 10:15:26 LSE    
624 439.000 17/09/2026 10:15:26 LSE    
186 439.500 17/09/2026 10:18:15 LSE    
126 441.500 17/09/2026 10:56:02 LSE    

For further information please contact:

Foresight Group Investors
Ben McGrory
+44 (0) 7443 821577
ir@foresightgroup.eu

Berenberg (Joint Corporate Broker)
James Felix / John Welch / Dan Gee-Summons
+44 (0) 203 753 7800

H-Advisors Maitland
Sam Cartwright / Audrey Da Costa
+44 (0) 782 725 4561 / +44 (0) 781 710 5562
Foresight@h-advisors.global

About Foresight Group Holdings Limited

Founded in 1984, Foresight is a leading investment manager in real assets and capital for growth, operating across the UK, Europe, and Australia.

With decades of experience, Foresight offers investors access to attractive investment opportunities at the forefront of change. Foresight actively builds and grows investment solutions to support the energy transition, decarbonise industry, enhance nature recovery and realise the economic potential of ambitious companies.

A constituent of the FTSE 250 index, Foresight’s diversified investment strategies combine financial and operational skillsets to maximise asset value and provide attractive returns to its investors. Its wide range of private and public funds is complemented with a variety of investment solutions designed for the retail market.

Foresight is united by a shared commitment to build a sustainable future and grow thriving companies and economies.

Visit https://foresight.group for more information.

Follow us on LinkedIn for key updates. 

 Not for release, publication or distribution, directly or indirectly, in or into the United States of America, or in or into Australia, Canada, Japan, South Africa or any other jurisdiction in which it would be unlawful to do so.

This press release is for information purpose only and does not constitute an offer to sell or a solicitation of an offer to buy any securities and the offer of the Bonds (as defined below) does not constitute an offering (other than to qualified investors) in any jurisdiction, including France.
The Bonds will be offered only to qualified investors which include, for the purpose of this press release, professional clients and eligible counterparties. The securities may not be offered or sold or otherwise made available to retail investors. No key information document under the PRIIPs Regulation or disclosure document required by the FCA Product Disclosure Sourcebook or the CCI Regulations has been or will be prepared.

Soitec announces the success of its offering of bonds settled in cash and/or convertible into new shares and/or exchangeable for existing shares (“ORNANEs”) due September 2033 for a nominal amount of €500 million

Bernin (Grenoble), France, on September 18, 2026 – Soitec (the “Company”), a world leader in the design and manufacturing of innovative semiconductor materials, announces today the success of its offering of bonds settled in cash and/or convertible into new shares and/or exchangeable for existing shares of the Company (“ORNANEs”) due September 2033 (the “Bonds”), by way of a placement to qualified investors (within the meaning of the Prospectus Regulation (as defined below)) only in accordance with Article L. 411-2, 1° of the French Code monétaire et financier, for a nominal amount of €500 million (the “Offering”).

Soitec will use the net proceeds from the Offering for general corporate purposes, which may include refinancing of existing indebtedness and investments to support the organic growth of the Company.

Albin Jacquemont, CFO of Soitec commented:

“The successful placement of our €500 million ORNANEs underscores the strong investor confidence in Soitec’s technological leadership and strategic positioning in enabling the next-generation AI infrastructure via our Photonics-SOI technologies. This issuance provides us with further financial flexibility, including to support our organic growth and refinancing. In light of the accelerating demand for our Photonics-SOI solutions, this placement is well-aligned with our ability to scale and meet increasing market demand. The placement was conducted under very favorable conditions for Soitec and its investors.”

Main terms of the Bonds

The Bonds will be issued with a denomination of €100,000 each (the “Principal Amount”) and will bear a coupon at a fixed rate of 0.5% per annum from the Issue Date (as defined below), payable annually in arrear on September 25 of each year (or if such date is not a business day, the following business day), and for the first time on September 25, 2027.
The conversion/exchange price has been set at €206.46, which represents a conversion/exchange premium of 55% above the reference share price of €133.20, being the placing price of a share in the Concurrent Accelerated Bookbuilding (as defined below).

The Bonds will be issued at 100% of their Principal Amount on September 25, 2026, the expected settlement and delivery date of the Bonds (the “Issue Date”). The settlement of the Concurrent Accelerated Bookbuilding (as defined below) is expected to take place on September 22, 2026.

Unless previously converted, exchanged, redeemed or purchased and cancelled in accordance with the terms and conditions of the Bonds, the Bonds will be redeemed at par on September 25, 2033 (the “Maturity Date”) (or on the following business day if this date is not a business day).

Bondholders will be entitled to require an early redemption of their Bonds on the 5th anniversary of the Issue Date of the Bonds, at their Principal Amount plus accrued interest.

Bondholders will be granted a conversion/exchange right of the Bonds into new and/or existing shares (the “Conversion/Exchange Right”) which they may exercise (a) from and including the Issue Date (i.e. September 25, 2026) until and including March 25, 2033 only under certain conditions described in the terms and conditions of the Bonds (including, in the event that the Company exercises its right to early redeem the Bonds, in the event of default, in the event of delisting, in the event of a public offer resulting in, or likely to result in, a change of control, or in the event of a parity event), and (b) at any time from and including March 26, 2033 until and including the 30th business day preceding the Maturity Date, or the relevant early redemption date, as the case may be. The initial conversion/exchange ratio has been set at 484.3553, corresponding to the nominal amount of a Bond divided by the initial conversion/exchange price (i.e., the reference share price increased by the conversion/exchange premium).

The ORNANE structure would allow to limit dilution for existing shareholders upon conversion, at the Company’s option. Upon exercise of their Conversion/Exchange Right, Bondholders will receive, at the option of the Company exclusively, an amount payable in cash or an amount payable in cash and in new and/or existing shares of Soitec. The Company will retain the option to deliver new and/or existing shares only. The cash amount that the Company may decide to pay will be calculated based on the average of volume-weighted average prices of the share over a 20-trading-day period beginning 2 trading days following the Company’s decision to deliver a cash amount to Bondholders, under the conditions described in the terms and conditions of the Bonds.

Shares delivered upon exercise of the Conversion/Exchange Right (if any) will be fully fungible with existing shares of the Company and will carry all rights attached to such shares as from the date of delivery of such shares.

The Bonds may be redeemed prior to the Maturity Date at the discretion of the Company, under certain conditions. In particular, the Bonds may be fully redeemed early at par plus accrued interest at Soitec’s option as from October 16, 2030 until the Maturity Date, if the arithmetic mean of daily products of the VWAP of Soitec’s share price on Euronext Paris and the prevailing conversion/exchange ratio, over a 20-consecutive trading day period chosen by the Company among 40 consecutive trading days preceding the publication of the early redemption notice, exceeds 130% of the Principal Amount of the Bonds. Bondholders will retain the ability to exercise their Conversion/Exchange Right under the conditions set out above.

Upon a Change of Control of the Company or a Delisting of the shares of the Company (as these terms are defined in the terms and conditions of the Bonds), all Bondholders will have an option to request the redemption of the Bonds before the Maturity Date at their Principal Amount plus accrued interest, as set out in the terms and conditions of the Bonds. Bondholders will retain the ability to exercise their Conversion/Exchange Right under the conditions set out above.

Application will be made for the Bonds to be admitted to trading on Euronext AccessTM within 30 calendar days following the Issue Date.

Concurrently with the Offering, and in order to facilitate hedging for certain subscribers of the Bonds, certain members of the bank syndicate acting as joint bookrunners of the Offering organized a simultaneous placement of existing shares in Soitec in short sales on behalf of those subscribers, at a placement price of €133.20, that has been determined via an accelerated bookbuilding process (the “Concurrent Accelerated Bookbuilding”). Soitec will not receive any proceeds from any sale of shares pursuant to the Concurrent Accelerated Bookbuilding.

Lock-up

In the context of the Offering, the Company has agreed to a lock-up undertaking for a period starting from today and ending 90 calendar days after the Issue Date, subject to certain customary exceptions.

Legal framework of the Offering

The Offering has been conducted by way of a placement to qualified investors only (within the meaning of article 2(e) of Regulation (EU) 2017/1129, as amended (the “Prospectus Regulation”)), in accordance with Article L. 411-2, 1° of the French monetary and financial code (Code monétaire et financier), as per the authorization granted by the Company’s extraordinary general meeting held on July 22, 2025 (19th resolution), in France and outside France (excluding in particular the United States of America, Japan, Canada, South Africa or Australia), without an offer to the public (other than to qualified investors) in any country (including France).

Existing shareholders of the Company shall have no preferential subscription rights, and there will be no priority subscription period, in connection with the issuance of the Bonds or the underlying shares of the Company issued upon conversion.

Any offer or sale of shares in the Concurrent Accelerated Bookbuilding has been made (A) in accordance with the provisions of Article L.411-2, 1° of the French monetary and financial code (Code monétaire et financier) and (B) (i) outside the United States in offshore transactions in reliance on Rule 903 of Regulation S under the US Securities Act of 1933 (the “Securities Act”) or (ii) inside the United States to qualified institutional buyers (as defined in Rule 144A under the Securities Act) pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Dilution

For illustrative purposes, as a result of the Offering and its final conditions, the potential dilution from the Offering would represent up to 6.3% of the outstanding share capital1, should the Company decide to exclusively deliver new shares upon exercise of the Conversion/Exchange Right.

For illustrative purposes, the below table sets out the potential dilution should Soitec deliver, upon exercise by all Bondholders of their Conversion/Exchange Right, (i) an amount in cash equal to the Principal Amount of the Bonds and (ii) the difference between the Conversion/Exchange Value (as defined in the terms and conditions of the Bonds) and the Principal Amount of the Bonds in shares:

  206.46 equal to 100% of the initial Conversion/Exchange price of the Bonds 237.43 equal to 115% of the initial Conversion/Exchange price of the Bonds 268.40 equal to 130% of the initial Conversion/Exchange price of the Bonds
Dilution1 0.0%1 / 0 new share 0.9%1 / 315,883 new shares 1.5%1 / 558,871 new shares

The above table has been prepared on the basis of the following assumptions:

  • a conversion/exchange premium of 55%;
  • a reference share price of €133.20, being the placing price of a share in the Concurrent Accelerated Bookbuilding;
  • a delivery of new shares only;
  • no adjustment of the conversion/exchange ratio.

 Available information

The Offering of the Bonds is not subject to a prospectus approved by the French Financial Market Authority (Autorité des Marchés Financiers) (the “AMF”). Detailed information on Soitec, including its business, results, prospects, liquidity position and related risk factors are described in the Company’s universal registration document (Document d’enregistrement universel) filed with the AMF on June 10, 2026 for the financial year ended March 31, 2026, under number D.26-0417, and the Q1 revenue press release for the first quarter ended June 30, 2026 published on July 22, 2026 which are available together with all the press releases and other regulated information about the Company, on Soitec website (www.soitec.com).

Important information

This press release does not constitute or form part of any offer or solicitation to purchase or subscribe for or to sell securities to any person in the United States of America, Australia, Canada, South Africa or Japan or in any jurisdiction to whom or in which such offer is unlawful, and the Offering of the Bonds is not an offer to the public in any jurisdiction, including France, other than to qualified investors within the meaning of the Prospectus Regulation, or an offer to retail investors as such term is defined below.

About Soitec

Soitec (Euronext – Tech Leaders – SBF 120), a world leader in innovative semiconductor materials, has been developing cutting-edge products delivering both technological performance and energy efficiency for over 30 years. From its global headquarters in France, Soitec is expanding internationally with its unique solutions, and generated sales of around 600 million euros in fiscal year 2025-2026. Soitec occupies a key position in the semiconductor value chain, serving three main strategic markets: Mobile Communications, Automotive and Industrial, and Edge and Cloud AI. The company relies on the talent and diversity of nearly 2000 employees, representing 50 different nationalities, working at its sites in Europe, the United States and Asia. Nearly 4,800 patents have been registered by Soitec.

Soitec, SmartSiC™ and Smart Cut™ are registered trademarks of Soitec.

For more information soitec.com and follow us on LinkedIn and X: @Soitec_Official

Investor Relations: investors@soitec.com

Media Relations: media@soitec.com

Disclaimer

This press release may not be released, published or distributed, directly or indirectly, in or into the United States of America (including its territories and dependencies, any state of the United States and the District of Columbia), or in or into Australia, Canada, South Africa or Japan. The distribution of this press release may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes, should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

No communication or information relating to the offering of the Bonds or the Concurrent Accelerated Bookbuilding may be distributed to the public in a country where a registration or approval is required. No action has been or will be taken in any country in which such registration or approval would be required. The issuance by the Company or the subscription of the Bonds and the Concurrent Accelerated Bookbuilding may be subject to legal and regulatory restrictions in certain jurisdictions; neither the Company, nor the joint bookrunners assume any liability in connection with the breach by any person of such restrictions.

This press release is an advertisement and not a prospectus within the meaning of Regulation (EU) 2017/1129, as amended (the “Prospectus Regulation”) and of the Public Offers and Admissions to Trading Regulations 2024 (the “POATRs”). This press release is not an offer to the public other than to qualified investors, or an offer to subscribe or designed to solicit interest for purposes of an offer to the public other than to qualified investors in any jurisdiction, including France.

The Bonds have been offered only by way of an offering in France and outside France (excluding the United States of America, Australia, Canada, South Africa, Japan and any other jurisdiction where a registration process or an approval would be required by applicable laws and regulations), solely to qualified investors as defined in article 2(e) of the Prospectus Regulation and in accordance with Article L. 411-2 1° of the French Monetary and Financial Code (Code monétaire et financier) and paragraph 15 of Schedule 1 to the POATRs. There has not been and will be no public offering in any country (including France) in connection with the Bonds, other than to qualified investors. This press release does not constitute a recommendation concerning the issue of the Bonds. The value of the Bonds and the shares of the Company can decrease as well as increase. Potential investors should consult a professional adviser as to the suitability of the Bonds for the person concerned.

PRIIPs Regulation / Prohibition of sales to European Economic Area retail investors

The Bonds are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to, and no action has been undertaken or will be undertaken to offer, sell or otherwise make available any Bonds to any retail investor in the European Economic Area (the “EEA”).

For the purposes of this provision, a “retail investor” means a person who is one (or more) of the following: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU, as amended (“MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97, as amended, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II or (iii) not a qualified investor within the meaning of the Prospectus Regulation. The expression “offer” includes the communication in any form and by any means of sufficient information on the terms of the offer and the Bonds to be offered so as to enable an investor to decide to purchase or subscribe the Bonds. Consequently, no key information document required by Regulation (EU) No 1286/2014, as amended (the “PRIIPs Regulation”) for offering or selling the Bonds or otherwise making them available to retail investors in the EEA has been or will be prepared and therefore offering or selling the Bonds or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation.

CCI Regulation / Prohibition of sales to UK retail Investors

The Bonds are not intended to be offered, sold, distributed or otherwise made available to and should not be offered, sold, distributed or otherwise made available to, and no action has been undertaken or will be undertaken to offer, sell or otherwise make available any Bonds to any retail investor in the United Kingdom (“UK”).

For the purposes of this provision, a “retail investor” means a person who is either one (or both) of the following: (i) not a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018; or (ii) not a qualified investor as defined in paragraph 15 of Schedule 1 to the POATRs. Consequently, no disclosure document required by the FCA Product Disclosure Sourcebook (“DISC”) for offering, selling or distributing the Bonds or otherwise making them available to retail investors in the UK has been prepared and therefore offering, selling or distributing the Bonds or otherwise making them available to any retail investor in the UK may be unlawful under DISC and the Consumer Composite Investments (Designated Activities) Regulations 2024.

MIFID II product governance / Professional investors and ECPs only target market – Solely for the purposes of each manufacturer’s product approval process, the target market assessment in respect of the Bonds has led to the conclusion that: (i) the target market for the Bonds is eligible counterparties and professional clients, each as defined in MiFID II; and (ii) all channels for distribution of the Bonds to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Bonds (a “distributor”) should take into consideration the manufacturers’ target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Bonds (by either adopting or refining the manufacturers’ target market assessment) and determining appropriate distribution channels.

UK MIFIR product governance / Professional investors and ECPs only target market – Solely for the purposes of the manufacturer’s product approval process, the target market assessment in respect of the Bonds has led to the conclusion that: (i) the target market for the Bonds is only eligible counterparties, as defined in the FCA Handbook Conduct of Business Sourcebook (“COBS”), and professional clients, as defined in Regulation (EU) No 600/2014, as amended, as it forms part of UK domestic law by virtue of the EUWA (“UK MiFIR”); and (ii) all channels for distribution of the Bonds to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Bonds (a “distributor”) should take into consideration the manufacturer’s target market assessment; however, a distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance Rules”) is responsible for undertaking its own target market assessment in respect of the Bonds (by either adopting or refining the manufacturer’s target market assessment) and determining appropriate distribution channels.

France

The Bonds have not been and will not be offered or sold or caused to be offered or sold, directly or indirectly, to the public in France other than to qualified investors. Any offer or sale of the Bonds and distribution of any offering material relating to the Bonds have been and will be made in France only to qualified investors (investisseurs qualifiés), as defined in article 2(e) of the Prospectus Regulation, and in accordance with Article L. 411-2 1° of the French Monetary and Financial Code (Code monétaire et financier).

United Kingdom

This press release is addressed and directed only at persons who (i) are located outside the United Kingdom, or (ii) are “qualified investors” within the meaning of paragraph 15 of Schedule 1 of the Public Offers and Admissions to Trading Regulations 2024 (x) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”), or (y) who fall within Article 49(2) (a) to (d) of the Order or (iii) to whom it may be lawfully communicated (all such persons together with qualified investors in the EEA being referred to as “Relevant Persons”). The Bonds and, as the case may be, the shares to be delivered upon exercise of the conversion/exchange rights (the “Financial Instruments”), are intended only for Relevant Persons and any invitation, offer or agreement related to the subscription, tender, or acquisition of the Financial Instruments may be addressed and/or concluded only with Relevant Persons. All persons other than Relevant Persons must abstain from using or relying on this document and all information contained therein.

This press release is not a prospectus which has been approved by the Financial Conduct Authority or any other United Kingdom regulatory authority for the purposes of Section 85 of the Financial Services and Markets Act 2000.

United States of America

This press release may not be released, published or distributed in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia). This press release does not constitute an offer or a solicitation of an offer of securities in the United States. The Bonds and the shares issued or deliverable upon conversion or exchange of the Bonds described in this press release have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any state of the United States, and such securities may not be offered, sold, pledged or otherwise transferred in the United States absent registration under the Securities Act or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements thereof and applicable state or local securities laws. The Company does not intend to make a public offer of its securities in the United States.

Australia, Canada, South Africa and Japan

The Bonds may not and will not be offered, sold or purchased in Australia, Canada, South Africa or Japan. The information contained in this press release does not constitute an offer of securities for sale in Australia, Canada, South Africa or Japan.

The distribution of this press release in certain countries may constitute a breach of applicable law.


1 Based on 35,814,320 shares in Soitec’s share capital

Attachment

TORONTO and PERTH, Western Australia, Sept. 18, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (Cygnus or the Company) provides the following update in relation to the proposed transaction under which Central Asia Metals PLC (AIM: CAML) (CAML) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (Scheme).

Cygnus refers to the explanatory statement released to the ASX on 13 August 2026, which includes information about the Scheme and notice of Scheme Meeting (Scheme Booklet). Capitalised terms used but not defined in this announcement have the meaning given to them in the Scheme Booklet.

TAKE NOTICE that at not before 2.15pm (AWST) on 23 September 2026,1 the Supreme Court of Western Australia at the David Malcolm Justice Centre, 28 Barrack Street, Perth, Western Australia will hear an application by Cygnus seeking the approval of a scheme of arrangement between Cygnus and its shareholders proposed by a resolution to be considered, and, if thought fit, passed at the meeting of the shareholders of Cygnus to be held at 2.00pm (AWST) on 18 September 2026 (Scheme Meeting).

If you wish to oppose the application for approval of the Scheme, you must file with the Supreme Court of Western Australia and serve on Cygnus a notice of appearance in respect of COR 101 of 2026, in the prescribed form, together with any affidavit on which you wish to rely at the hearing. The notice of appearance and affidavit must be served on Cygnus at its address for service at least 1 day before the date fixed for the hearing of the application. The address for service of Cygnus is Hamilton Locke, Level 39, 152-158 St Georges Terrace, Perth WA 6000, attention: James Nicholls.

This announcement is authorised for release by the Board of Cygnus Metals Limited.

David Southam Nicholas Kwong Media:
Executive Chair President & CEO Paul Armstrong
T: +61 8 6118 1627 T: +1 418 748 5076 Read Corporate
E: info@cygnusmetals.com E: info@cygnusmetals.com T: +61 8 9388 1474

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this announcement may constitute “forward-looking information” within the meaning of applicable securities laws. Examples of forward-looking statements in this announcement include, among others, statements regarding: the completion of the Scheme and the remaining related steps therefor, including timing thereof. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or timing to differ materially from those anticipated or implied by such forward-looking information. Information about the risks and assumptions affecting the forward-looking information herein can be found in the “Risk Factors” section in the Scheme Booklet dated 13 August 2026, a copy of which is available under Cygnus’ profile on SEDAR+ at www.sedarplus.ca. All of the forward-looking information in this announcement is qualified by these cautionary statements. Cygnus assumes no obligation to publicly update or revise such information, except as may be required by applicable law and the rules of the ASX and the TSX Venture Exchange.  

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

___________________________
1
The Second Court Hearing may not take place at this time and date if all of the conditions precedent to the Scheme (other than approval of the Scheme at the Second Court Hearing) have not been satisfied or waived (as applicable) before the Delivery Time on the Second Court Date. Details of the conditions precedent to the Scheme are included in section 8.4(c) and Schedule 1 of the Scheme Booklet. For a full copy of the Scheme Booklet, refer to Cygnus’ ASX announcement dated 13 August 2026 titled “Scheme Booklet Registered”. Cygnus Shareholders should refer to Cygnus’ ASX announcement dated 14 September 2026 titled “Update on Scheme of Arrangement” which provides an update on the status of the conditions precedent to the Scheme, including the Kazakstan regulatory approval condition precedent which has not yet been satisfied. Any changes to the Second Court Date or the Scheme timetable set out in the Scheme Booklet will be announced to ASX and available under Cygnus’ profile at www.asx.com.au.

[Ad hoc announcement pursuant to Art. 53 LR]

………….

Update on Nestlé’s operations in Russia

Nestlé takes note of Russia’s presidential decree, published yesterday, that places Nestlé Russia under temporary external administration. The company is assessing the situation and its options.

Nestlé is committed to taking all necessary steps to protect its rights and ensure continuity of business operations in the interests of all stakeholders, particularly its employees.

 


 

Contacts:

Media:
Christoph Meier  Tel.: +41 21 924 2200
mediarelations@nestle.com

Investors:
David Hancock  Tel.: +41 21 924 3509
ir@nestle.com

 

VALLOUREC WINS A CONTRACT FOR THE PRINOS CO2 CARBON STORAGE PROJECT IN GREECE

Meudon (France), on September 18, 2026 – Vallourec, a world leader in premium seamless tubular solutions, announces that it has been selected by EnEarth, a subsidiary of Energean, to supply premium tubular solutions for the first phase of the Prinos CO2 Carbon Storage project in Greece. The contract covers approximately 3,000 tons of casing pipes and accessories. 

Located offshore Greece, Prinos CO2 is one of Europe’s most advanced Carbon Storage projects. It aims to convert depleted oil reservoir into a permanent CO₂ storage site, with a targeted injection capacity of up to 2.8 million tons per year and a total  ̶  proved plus probable  ̶  storage capacity of 51.5 million tons, as per NSAI’s (Netherland, Sewell & Associates, Inc) independent Competent Person’s Report.

Recognized by the European Union as a Project of Common Interest and supported by European and Greek funding programs, Prinos CO₂ is expected to contribute to the decarbonization of industrial activities in Greece and across the wider Eastern Mediterranean region.

Under the contract, Vallourec will deliver a comprehensive package of premium tubular solutions, including seamless carbon steel and corrosion-resistant alloy (CRA) casing pipes equipped with VAM® premium connections, recognized for their superior sealing performance and reliability. These solutions are designed to ensure long-term well integrity, a critical requirement for the safe and permanent storage of CO₂. The scope also includes CLEANWELL®, Vallourec’s dope-free solution, which enhances operational efficiency while reducing environmental impact.

This award represents a significant milestone for Vallourec’s Carbon Capture and Storage business and strengthens its position as a trusted partner for carbon storage projects. It also provides a strong platform for Vallourec to support the future development phases of Prinos CO₂ and additional Carbon Capture and Storage opportunities across Europe.

Philippe Guillemot, Chairman of the Board of Directors and Chief Executive Officer commented: “We are proud to have been selected for the Prinos CO2 Carbon Storage project, one of Europe’s most advanced Carbon Capture and Storage developments. This award demonstrates the confidence placed in Vallourec’s ability to provide premium tubular solutions that meet the stringent integrity and reliability requirements of permanent CO₂ storage. It also marks an important step in the development of our Carbon Capture and Storage business and illustrates our commitment to supporting our customers in delivering strategic energy transition projects.” 

Nikolas Rigas, Head of Carbon Storage in EnEarth, commented: “The Prinos CO₂ Storage project is one of the first large-scale Carbon Capture and Storage developments to be built in Europe and the first of its kind in the Eastern Mediterranean. Projects of this significance are founded on safety, reliability, and long-term integrity. As Europe accelerates its decarbonization journey, infrastructure such as Prinos will play a critical role in enabling industry to reduce emissions while remaining competitive. The selection of Vallourec reflects our commitment to partnering with world-class companies whose expertise and technology will help ensure the safe and permanent storage of CO₂ for decades to come.”
 
About Vallourec

Vallourec is a world leader in premium tubular solutions for the energy markets and for demanding industrial applications such as oil & gas wells in harsh environments, new generation power plants, challenging architectural projects, and high-performance mechanical equipment. Vallourec’s pioneering spirit and cutting-edge R&D open new technological frontiers. With close to 13,000 dedicated and passionate employees in more than 20 countries, Vallourec works hand- in-hand with its customers to offer more than just tubes: Vallourec delivers innovative, safe, competitive and smart tubular solutions, to make every project possible.
Listed on Euronext in Paris (ISIN code: FR0013506730, Ticker VK), Vallourec is part of the CAC Mid 60, SBF 120 and Next 150 indices and is eligible for Deferred Settlement Service.
In the United States, Vallourec has established a sponsored Level 1 American Depositary Receipt (ADR) program (ISIN code: US92023R4074, Ticker: VLOWY). Parity between ADR and a Vallourec ordinary share has been set at 5:1.

For further information, please contact:

Investor relations:
Daniel Thomson
Tel: +44 (0)75 91 83 74 05
daniel.thomson@vallourec.com

Individual shareholders:
Toll Free number (From France): 0 805 65 10 10 
actionnaires@vallourec.com

Press relations: Taddeo
Romain Grière
Tel: +33 (0)7 86 53 17 29
romain.griere@taddeo.fr

Nicolas Escoulan
Tel: +33 (0)6 42 19 14 74
nicolas.escoulan@taddeo.fr

Attachment

NEW YORK, NY, Sept. 17, 2026 (GLOBE NEWSWIRE) — Host Digital Inc. (f/k/a Healthy Choice Wellness Corp.) (NYSE American: HCWC) (the “Company” or “Host Digital”) today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 2,187,500 shares of its Class A common stock, par value $0.001 (the “Common Stock”), at a public offering price of $8.00 per share, for aggregate gross proceeds to the Company of $17.5 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Offering is expected to close on September 21, 2026, subject to the satisfaction of customary closing conditions.

The Company has granted the underwriters of the Offering a 30-day option to purchase up to an additional 328,125 shares of its Common Stock at the public offering price, less underwriting discounts and commissions.

The Company intends to use the net proceeds from the Offering for data center investments, general and administrative expenses, capital expenditures, working capital and other general corporate purposes

Cantor is acting as lead book-running manager for the Offering. Siebert, A.G.P. and Clear Street are acting as joint book-running managers for the Offering.

The Offering is being made by means of a prospectus supplement under the Company’s effective registration statement on Form S-3 (File No. 333-291258), as filed with the Securities and Exchange Commission (the “SEC”). A final prospectus supplement and accompanying prospectus relating to the Offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement and accompanying prospectus relating to the Offering may also be obtained, when available, from Cantor Fitzgerald & Co., Attention: Equity Capital Markets, 110 East 59th Street, 6th Floor, New York, NY 10022, or by email at prospectus@cantor.com.

No Offer or Solicitation

This press release is not intended to be, and shall not constitute, an offer to buy or sell, or the solicitation of an offer to buy or sell, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under applicable securities laws. No offering of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

About Host Digital Inc.

Host Digital is a digital infrastructure company focused on the development, acquisition, ownership and operation of institutional-quality data centers in the United States, with a focus on supporting artificial intelligence (“AI”) and high-performance computing (“HPC”) workloads. The Company’s strategy prioritizes sites with existing or near-term access to power, right-sized development opportunities and long-term contracts with strong or credit-enhanced counterparties. The Company seeks to own and control the real estate, power and data center infrastructure underlying its projects and to provide turnkey facilities that allow tenants to select and deploy their own compute infrastructure and model layers.

Following its business combination with Host Digital Infrastructure LLC, the Company also owns and operates a portfolio of natural and organic grocery stores through its wholly owned subsidiaries, consisting of 19 locations across six states operating under the Ada’s Natural Market, Paradise Health & Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s and GreenAcres Market brands.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the proposed Offering, including the anticipated closing date of the Offering; the anticipated use of proceeds from the Offering; the potential exercise by the underwriters of their option to purchase additional shares; and the Company’s ability to execute and scale its business model. Statements that are not historical facts are based on current estimates, assumptions and projections and are not guarantees of future performance. Words such as “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,” “will,” “would,” “could” and similar expressions identify forward-looking statements, although not all forward-looking statements contain these words.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, including risks relating to the completion of the Offering on the anticipated terms or at all; the Company’s ability to satisfy the applicable listing requirements; the Company’s ability to successfully integrate the businesses and realize the anticipated benefits of the Offering; the Company’s ability to obtain required financing, complete development and deliver capacity on schedule; and other factors described in the Company’s filings with the SEC. The Company undertakes no obligation to update these statements except as required by law.

Contact Information

Jessica Starman
jessica@elev8newmedia.com
888-461-2233

SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced the closing of its previously announced public offering of an aggregate 4,322,489 Class A Ordinary Shares (“the Offering”) at a price of $1.15 per share (“the Offering Price”) to the public, for a total of approximately $4.97 million of gross proceeds to the Company, before deducting underwriting discounts and offering expenses.

The Company has granted the underwriter a 45-day option to purchase up to an additional 648,373 shares of its Class A Ordinary Shares at the Offering Price, representing 15% of the Class A Ordinary Shares sold in the Offering (“the Over-allotment”). Assuming that the Over-allotment is exercised, the Company is expected to receive gross proceeds amounting to approximately $5.72 million, before deducting underwriting discounts and commissions and estimated offering expenses.

The Company intends to use net proceeds from the Offering for expansion into new businesses, R&D activities to expand its product offerings, growth and expansion into new markets, building brand awareness, investment in equipment and infrastructure, and working capital and general corporate purposes.

R. F. Lafferty & Co., Inc. (“R. F. Lafferty”), acted as the sole book-running manager for the Offering. Loeb & Loeb LLP, Lee & Lee, Harney Westwood & Riegels Singapore LLP are acting as U.S., Singapore and Cayman Islands legal counsels to the Company, respectively, and Ellenoff Grossman & Schole LLP is acting as U.S. legal counsel to R. F. Lafferty for the Offering.

“We thank our new and existing shareholders for their support in this Offering,” said David Quek, Chief Executive Officer of Cuprina. “The Offering comes at an important stage for the Company, following U.S. FDA 510(k) clearance for MEDIFLY Maggots™ in June. We intend to use the net proceeds as described in our prospectus, including building out our new business collaborations, advancing our wound care pipeline, and expanding into new markets.”

“Chronic wounds remain the core of our business. We believe demand for effective wound care will keep growing as populations age and rates of diabetes, obesity, cardiovascular disease and peripheral vascular disease rise. We also believe our approach, which uses materials derived from natural sources, positions Cuprina to meet that need, and we look forward to updating shareholders on our progress.”

The Offering is being conducted pursuant to the Company’s Registration Statement on Form F-1 (File No: 333-297299) previously filed with and subsequently declared effective by the U.S. Securities and Exchange Commission (“SEC”) on September 15, 2026. The Offering is being made only by means of a prospectus. Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. Copies of the final prospectus related to the Offering may be obtained, when available, from R. F. Lafferty & Co., Inc., 40 Wall Street, Suite 3602, New York, NY 10005; (212) 293-9090, or by email at offerings@rflafferty.com. In addition, a copy of the final prospectus, when available, relating to the Offering may be obtained via the SEC’s website at www.sec.gov.

This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Cuprina Holdings (Cayman) Limited

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the infertility, medical waste recycling, and health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information, please visit https:// www.cuprina.com.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the gross proceeds of the offering. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Cuprina Holdings (Cayman) Limited specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Cuprina Holdings (Cayman) Limited Investor Contact
Investor Relations
c/o Blk 1090 Lower Delta Road #06-08
Singapore 169201
+65 8512 7275
Email: ir@cuprina.com.sg

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) — Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer, today announced the pricing of its upsized initial public offering of 23,333,334 shares of common stock at a price to the public of $15.00 per share. The gross proceeds to Electra from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Electra, are expected to be approximately $350.0 million. In addition, Electra has granted the underwriters a 30-day option to purchase up to an additional 3,500,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being offered by Electra.

The shares are expected to begin trading on The Nasdaq Global Select Market on September 18, 2026, under the ticker symbol “ETRA.” The offering is expected to close on September 21, 2026, subject to the satisfaction of customary closing conditions.
Jefferies, TD Cowen, Evercore ISI and Cantor are acting as joint book-running managers for the offering.

Registration statements relating to these securities have been filed with the U.S. Securities and Exchange Commission (SEC) and became effective on September 17, 2026. Copies of the registration statements can be accessed through the SEC’s website at www.sec.gov. This offering is being made only by means of a prospectus forming part of the registration statements relating to these securities. When available, copies of the final prospectus relating to the initial public offering may be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com; TD Securities (USA) LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at TDManualrequest@broadridge.com; Evercore Group L.L.C., 55 East 52nd Street, 35th Floor, New York, New York 10055, Attention: Equity Capital Markets, or by email at ecm.prospectus@evercore.com or by telephone at (888) 474-0200; or Cantor Fitzgerald & Co., Attention: Equity Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022, or by email at prospectus@cantor.com.
This press release does not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Electra Therapeutics

Electra Therapeutics is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company’s novel approach targets signal regulatory proteins (SIRP), a family of cell surface receptors whose expression is restricted to specific immune cell populations and increases upon activation, to enable selective depletion of disease-driving cells while preserving normal immune function. The company’s lead product candidate, ipsoprubart (ELA026), is a novel pan-SIRP monoclonal antibody currently in a global registrational program for secondary hemophagocytic lymphohistiocytosis (sHLH), a severe hyperinflammatory syndrome for which there are no broadly approved therapies and survival has remained consistently poor over the past two decades. Ipsoprubart is also being evaluated in a Phase 1 clinical trial in patients with relapsed/refractory T-cell and natural-killer cell malignancies. ELA822, the company’s second clinical-stage product candidate, is a novel SIRPγ-specific antibody being developed for a broad range of chronic T cell-mediated immune and inflammatory diseases.

Contacts:

Investor Contact:
Monique Allaire, THRUST
monique@thrustsc.com

Media Contact:
Sara Sutton, THRUST
sarah@thrustsc.com

GRAND RAPIDS, Mich., Sept. 17, 2026 (GLOBE NEWSWIRE) — Meritage Hospitality Group Inc. (OTCQX: MHGU) (“Meritage” or the “Company”), one of the nation’s largest restaurant operators, today announced that it has voluntarily filed petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Western District of Michigan (the “Court”). The Company took this step to strengthen its balance sheet and establish a sustainable capital structure that positions Meritage for long-term success.

Meritage presently operates 314 Wendy’s, one Bojangles and five independently branded concepts across 15 states. The Company anticipates maintaining restaurant-level operations during the restructuring process and intends to continue paying its approximately 9,000 team members their wages and benefits without interruption, subject to Court approval of customary “first day” motions described below. The Company also intends to continue honoring its commitments to guests and to pay suppliers and vendors in the ordinary course for goods and services provided on or after the filing date.

The filing follows a candid assessment of the financial pressures facing the Company, including the sustained system-wide headwinds affecting the broader Wendy’s brand over the past few years. The Company has a high level of confidence in the opportunity for a brand turnaround. Because the substantial majority of Meritage’s restaurant portfolio operates under Wendy’s brand, those system-wide pressures have had a significant impact on the Company’s financial position. After more than a year of working constructively with its lenders and its franchisor toward a solution, the Company’s Board of Directors and management team determined that a voluntary, court-supervised restructuring is the most effective and proactive path to strengthen Meritage’s finances, address these headwinds directly, and protect the long-term interests of its stakeholders, team members, guests, and communities.

Financing and Liquidity

The Company is in the process of obtaining debtor-in-possession (“DIP”) financing and expects this financing, together with cash generated from ongoing operations, to provide sufficient liquidity to support the business and meet its obligations throughout the Chapter 11 process. In connection with the filing, the Company will file a series of customary “first day” motions seeking Court authorization to continue paying employee wages and benefits, to honor certain customer programs, and to obtain other necessary relief so that it can maintain operations in the ordinary course.

Restructuring Plan and Path Forward

The Company believes that the Chapter 11 process will enable it to strengthen its balance sheet and create financial flexibility. The Company plans to use this process to connect with key stakeholders and determine the best way to maximize value for all stakeholders.

The Company’s restaurants will continue to serve guests every day, and its team members remain the heart of this business. This process will provide the Company with the tools to address its financial pressures and allow it to explore all strategic alternatives to maximize value on a timeline and with a plan to position the business for long-term success. The Company remains grateful for the continued loyalty and commitment of its team members, guests, vendors, and communities as it moves forward through this restructuring process.

Advisors

McDonald Hopkins LLC is serving as legal counsel and Fort Dearborn Partners is serving as restructuring advisor to the Company in connection with this process.

Additional Information and Court Filings

Court filings and information about the Chapter 11 process are available on a website maintained by the Company’s proposed claims and noticing agent, Kroll (https://restructuring.ra.kroll.com/Meritage/). Employees, vendors, and other stakeholders with questions may also contact mediarelations@mhgi.net.

About the Company

Meritage Hospitality Group currently operates 314 restaurants located in Arkansas, Connecticut, Florida, Georgia, Indiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, Ohio, Oklahoma, Tennessee, Texas, and Virginia. Meritage is headquartered in Grand Rapids, Michigan, operating with a workforce of approximately 9,000 employees. As of June 28, 2026, the Company had fully diluted weighted average common shares outstanding of 6,720,000.

The Company’s current and publicly available information pursuant to amended SEC Rule 15c2-11 and FINRA Rule 6432 can be found at www.otcmarkets.com, under the stock symbol MHGU/Disclosures or the Company’s website, www.meritagehospitality.com.

Forward Looking Statements
Certain statements contained in this release and the reports we submit to the OTC, including this release, that are not historical facts constitute forward-looking statements. Factors set forth in our Safe Harbor Statement, in addition to other possible factors not listed, could affect the Company’s actual results and cause such results to differ materially from those expressed in forward-looking statements. Please review the Company’s Safe Harbor Statement at http://www.meritagehospitality.com.

CONTACT: mediarelations@mhgi.net
Meritage Hospitality Group Inc.
(616) 776-2600

GRAND RAPIDS, Mich., Sept. 17, 2026 (GLOBE NEWSWIRE) — Meritage Hospitality Group Inc. (OTCQX: MHGU) (“Meritage” or the “Company”), one of the nation’s largest restaurant operators, today announced that it has voluntarily filed petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Western District of Michigan (the “Court”). The Company took this step to strengthen its balance sheet and establish a sustainable capital structure that positions Meritage for long-term success.

Meritage presently operates 314 Wendy’s, one Bojangles and five independently branded concepts across 15 states. The Company anticipates maintaining restaurant-level operations during the restructuring process and intends to continue paying its approximately 9,000 team members their wages and benefits without interruption, subject to Court approval of customary “first day” motions described below. The Company also intends to continue honoring its commitments to guests and to pay suppliers and vendors in the ordinary course for goods and services provided on or after the filing date.

The filing follows a candid assessment of the financial pressures facing the Company, including the sustained system-wide headwinds affecting the broader Wendy’s brand over the past few years. The Company has a high level of confidence in the opportunity for a brand turnaround. Because the substantial majority of Meritage’s restaurant portfolio operates under Wendy’s brand, those system-wide pressures have had a significant impact on the Company’s financial position. After more than a year of working constructively with its lenders and its franchisor toward a solution, the Company’s Board of Directors and management team determined that a voluntary, court-supervised restructuring is the most effective and proactive path to strengthen Meritage’s finances, address these headwinds directly, and protect the long-term interests of its stakeholders, team members, guests, and communities.

Financing and Liquidity

The Company is in the process of obtaining debtor-in-possession (“DIP”) financing and expects this financing, together with cash generated from ongoing operations, to provide sufficient liquidity to support the business and meet its obligations throughout the Chapter 11 process. In connection with the filing, the Company will file a series of customary “first day” motions seeking Court authorization to continue paying employee wages and benefits, to honor certain customer programs, and to obtain other necessary relief so that it can maintain operations in the ordinary course.

Restructuring Plan and Path Forward

The Company believes that the Chapter 11 process will enable it to strengthen its balance sheet and create financial flexibility. The Company plans to use this process to connect with key stakeholders and determine the best way to maximize value for all stakeholders.

The Company’s restaurants will continue to serve guests every day, and its team members remain the heart of this business. This process will provide the Company with the tools to address its financial pressures and allow it to explore all strategic alternatives to maximize value on a timeline and with a plan to position the business for long-term success. The Company remains grateful for the continued loyalty and commitment of its team members, guests, vendors, and communities as it moves forward through this restructuring process.

Advisors

McDonald Hopkins LLC is serving as legal counsel and Fort Dearborn Partners is serving as restructuring advisor to the Company in connection with this process.

Additional Information and Court Filings

Court filings and information about the Chapter 11 process are available on a website maintained by the Company’s proposed claims and noticing agent, Kroll (https://restructuring.ra.kroll.com/Meritage/). Employees, vendors, and other stakeholders with questions may also contact mediarelations@mhgi.net.

About the Company

Meritage Hospitality Group currently operates 314 restaurants located in Arkansas, Connecticut, Florida, Georgia, Indiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, Ohio, Oklahoma, Tennessee, Texas, and Virginia. Meritage is headquartered in Grand Rapids, Michigan, operating with a workforce of approximately 9,000 employees. As of June 28, 2026, the Company had fully diluted weighted average common shares outstanding of 6,720,000.

The Company’s current and publicly available information pursuant to amended SEC Rule 15c2-11 and FINRA Rule 6432 can be found at www.otcmarkets.com, under the stock symbol MHGU/Disclosures or the Company’s website, www.meritagehospitality.com.

Forward Looking Statements
Certain statements contained in this release and the reports we submit to the OTC, including this release, that are not historical facts constitute forward-looking statements. Factors set forth in our Safe Harbor Statement, in addition to other possible factors not listed, could affect the Company’s actual results and cause such results to differ materially from those expressed in forward-looking statements. Please review the Company’s Safe Harbor Statement at http://www.meritagehospitality.com.

CONTACT: mediarelations@mhgi.net
Meritage Hospitality Group Inc.
(616) 776-2600

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.